AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Roohi Ismail‐Khan'
:
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors
Publication Year: 2014
DOI: https://doi.org/10.18632/oncotarget.2357
Abstract:
Add to Library
Authors:
Hatem Soliman
Erica L. Jackson
Tony Neuger
Elizabeth Claire Dees
R. Donald Harvey
Hyo S. Han
Roohi Ismail‐Khan
Susan Minton
Nicholas N. Vahanian
Charles Link
Daniel M. Sullivan
Scott Antonia
A phase I study of indoximod in patients with advanced malignancies
Publication Year: 2016
DOI: https://doi.org/10.18632/oncotarget.8216
Abstract:
Add to Library
Authors:
Hatem Soliman
Susan Minton
Hyo S. Han
Roohi Ismail‐Khan
Anthony Neuger
Fatema Khambati
David Noyes
Richard M. Lush
Alberto Chiappori
John D. Roberts
Charles Link
Nicholas N. Vahanian
Mario R. Mautino
Howard Streicher
Daniel M. Sullivan
Scott Antonia
A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer
Publication Year: 2018
DOI: https://doi.org/10.18632/oncotarget.24118
Abstract:
Add to Library
Authors:
Hatem Soliman
Fatema Khambati
Hyo S. Han
Roohi Ismail‐Khan
Marilyn M. Bui
Daniel M. Sullivan
Scott Antonia
Abstract LB-216: NCI 9455: Phase II study of trametinib followed by trametinib plus AKT inhibitor,GSK2141795 in patients with advanced triple negative breast cancer
Publication Year: 2016
DOI: https://doi.org/10.1158/1538-7445.am2016-lb-216
Abstract:
Add to Library
Authors:
Bhuvaneswari Ramaswamy
Ewa Mrózek
Maryam B. Lustberg
Robert Wesolowski
Rachel M. Layman
Mahmoud Abdel‐Rasoul
Cynthia Timmers
Robyn Patrick
Jennifer Sexton
Erin Macrae
Charles L. Shapiro
Thomas Budd
Lyndsay N. Harris
Claudine Isaacs
Roohi Ismail‐Khan
Claire Dees
Andrew Poklepovic
Micheal R. Grever
Helen Chen
Miguel A. Villalona
William E. Carson
Abstract PD13-12: PD13-12 Imlunestrant, an oral selective estrogen receptor degrader, in combination with abemaciclib with or without an aromatase inhibitor, in estrogen receptor-positive advanced breast cancer: Results from the phase 1a/b EMBER study
Publication Year: 2023
DOI: https://doi.org/10.1158/1538-7445.sabcs22-pd13-12
Abstract:
Add to Library
Authors:
Komal Jhaveri
Hwei-Chung Wang
X. Cynthia
Elgene Lim
Jessica J. Tao
Luís Manso
Jean‐Yves Pierga
Ritesh Parajuli
Yolanda Jerez Gilarranz
Yen‐Shen Lu
Muralidhar Beeram
Tim Larson
Ajay Dhakal
Roohi Ismail-Khan
Claudia Karacsonyi
Shanshan Cao
Cynthia R. Osborne
Shawn T. Estrem
Bastien Nguyen
Yujia Li
Eunice Yuen
Abstract OT1-01-02: EMBER-4: A phase 3 adjuvant trial of imlunestrant vs standard endocrine therapy (ET) in patients with ER+, HER2- early breast cancer (EBC) with an increased risk of recurrence who have previously received 2 to 5 years of adjuvant ET
Publication Year: 2023
DOI: https://doi.org/10.1158/1538-7445.sabcs22-ot1-01-02
Abstract:
Add to Library
Authors:
Komal Jhaveri
Joyce O’Shaughnessy
Fabrice André
Matthew P. Goetz
Nadia Harbeck
M Navarro
François‐Clément Bidard
Zachary M. Thomas
Suzanne R.L. Young
Roohi Ismail-Khan
Lillian M. Smyth
Michael Gnant
#JACCCardioOnc
Publication Year: 2021
DOI: https://doi.org/10.1016/j.jaccao.2021.08.004
Abstract:
Add to Library
Authors:
Sherry‐Ann Brown
Eric H. Yang
Nosheen Reza
Avirup Guha
Roohi Ismail‐Khan
Naveen Pemmaraju
Michael G. Fradley
Juan Lopez‐Mattei
Abstract P6-10-06: A preoperative window-of-opportunity study of imlunestrant in estrogen receptor-positive, HER2-negative early breast cancer: Results from the EMBER-2 study
Publication Year: 2023
DOI: https://doi.org/10.1158/1538-7445.sabcs22-p6-10-06
Abstract:
Add to Library
Authors:
Patrick Neven
Nicole Stahl
María Vidal
Miguel Martín
Nadia Harbeck
Peter A. Kaufman
François‐Clément Bidard
Peter A. Fasching
Philippe Aftimos
Erika Hamilton
Stacey Carter
Peter Schmid
Duncan Wheatley
Manali Bhave
Kelly K. Hunt
Swati Kulkarni
Roohi Ismail-Khan
Claudia Karacsonyi
Shawn T. Estrem
Umut Özbek
Bastien Nguyen
Eva Ciruelos
Abstract P2-15-04: A phase 1/2 study of Ad.p53 DC vaccine with indoximod immunotherapy in metastatic breast cancer
Publication Year: 2015
DOI: https://doi.org/10.1158/1538-7445.sabcs14-p2-15-04
Abstract:
Add to Library
Authors:
Hatem Soliman
Susan Minton
Roohi Ismail‐Khan
Hyo S. Han
Nicholas N. Vahanian
Charles J. Link
G Kennedy
Howard Streicher
Daniel M. Sullivan
Scott Antonia
Abstract PS15-09: Imlunestrant monotherapy and in combination with abemaciclib, with or without an aromatase inhibitor, in estrogen receptor-positive (ER+), HER2-negative (HER2-) advanced breast cancer (aBC): updated results from the EMBER study
Publication Year: 2024
DOI: https://doi.org/10.1158/1538-7445.sabcs23-ps15-09
Abstract:
Add to Library
Authors:
Komal Jhaveri
Elgene Lim
Rinath Jeselsohn
X. Cynthia
Erika Hamilton
Cynthia R. Osborne
Manali Bhave
Peter A. Kaufman
J. Thaddeus Beck
Luís Manso
Ritesh Parajuli
Hwei-Chung Wang
Jessica Tao
Ajay Dhakal
Jean‐Yves Pierga
Yen‐Shen Lu
Tim Larson
Yolanda Jerez Gilarranz
Roohi Ismail‐Khan
F Bacchion
Claudia Karacsonyi
Yujia Li
Shawn T. Estrem
Bastien Nguyen
Muralidhar Beeram
Abstract CT087: Ribociclib + endocrine therapy (ET) doublet combinations in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Phase I clinical activity and impact of molecular alterations
Publication Year: 2017
DOI: https://doi.org/10.1158/1538-7445.am2017-ct087
Abstract:
Add to Library
Authors:
Dejan Juric
Mario Campone
Pamela N. Münster
Roohi Ismail‐Khan
Laura García‐Estévez
Mariana Chávez‐MacGregor
Antonio Frassoldati
Rina Hui
Ingrid A. Mayer
Javier Cortés
Anthony Gonçalvès
Richard H. De Boer
Luc Dirix
Sara M. Tolaney
Soo Chin Lee
Michela Maur
Yingbo Wang
Faye Su
Jason R. Dobson
Caroline Germa
Becker Hewes
Aditya Bardia
Abstract PD1-04: Results of a phase II double-blinded, randomized, placebo-controlled clinical trial of Indoximod, an Indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor, in combination with Taxane chemotherapy in metastatic breast cancer (MBC)
Publication Year: 2020
DOI: https://doi.org/10.1158/1538-7445.sabcs19-pd1-04
Abstract:
Add to Library
Authors:
Veronica Mariotti
Shou‐Ching Tang
Patrick M. Dillon
Alberto J. Montero
Andrew Poklepovic
Susan A. Melin
Nuhad Ibrahim
Petros Nikolinakos
Eugene P. Kennedy
Hyo S. Han
Roohi Ismail‐Khan
Daniel Bruetman
Oana C. Danciu
Paul Gilman
Bogusława Karaszewska
Krzysztof Leśniewski-Kmak
Timothy J. Panella
Dhimant Patel
Małgorzata Suszko-Każarnowicz
Fabio Volterra
Hatem Soliman
Error in Author Name
Publication Year: 2020
DOI: https://doi.org/10.1001/jamaoncol.2020.7303
Abstract:
Add to Library
Authors:
Drought or/and Heat-Stress Effects on Seed Filling in Food Crops: Impacts on Functional Biochemistry, Seed Yields, and Nutritional Quality
Publication Year: 2018
DOI: https://doi.org/10.3389/fpls.2018.01705
Abstract:
Add to Library
Authors:
Akanksha Sehgal
Kumari Sita
Kadambot H. M. Siddique
Rakesh Kumar
Sailaja Bhogireddy
Rajeev K. Varshney
Bindumadhava HanumanthaRao
Ramakrishnan M. Nair
P. V. Vara Prasad
Harsh Nayyar
Abstract P5-13-18: Upregulation of immune response biomarkers by ribociclib plus endocrine therapy (ET) in paired tumor samples from phase I studies
Publication Year: 2022
DOI: https://doi.org/10.1158/1538-7445.sabcs21-p5-13-18
Abstract:
Add to Library
Authors:
Dejan Juric
Chong Ma
Ralph Tiedt
Yoon Sim Yap
Joanne Chiu
Pamela N. Münster
Roohi Ismail‐Khan
Laura García‐Estévez
Ingrid A. Mayer
Carlos Becerra
Nadia Solovieff
Agnes Lteif
Faye Su
Yen‐Shen Lu
Found 26 results in 0.1 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"